Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 39
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/1/1999
 
First Published:
5/1/1998
1.
Phase IV Study of Photodynamic Therapy Using Porfimer Sodium in Patients with Partially Obstructive Esophageal Cancer (Summary Last Modified 01/99)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Closed
18 and over
Pharmaceutical / Industry
QLT-PHO-ECI-01
NCI-V98-1399
Last Modified:
1/1/2000
 
First Published:
5/1/1998
2.
Phase III Randomized Study of Photodynamic Therapy Using Porfimer Sodium for the Ablation of High Grade Dysplasia in Barrett's Esophagus
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention, Treatment
Closed
18 and over
Pharmaceutical / Industry
QLT-PHO-BAR-01
NCI-V98-1398
Last Modified:
10/2/2003
 
First Published:
4/1/1999
3.
Phase III Randomized Study of Photodynamic Therapy Using Porfimer Sodium (Photofrin) in Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Other
HEALTHONE-43892
HEALTHONE-1A, HEALTHONE-CA43892, RPCI-DS-9802, NCI-V99-1525, NCT00003788
Last Modified:
3/1/1988
4.
Phase III Randomized Study of Photodynamic Therapy with Photofrin II and Laser Light vs BCG as Prophylaxis in Patients with Resected Superficial Bladder Cancer Who Have a History of Recurrence (Summary Last Modified 03/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
UUMC-2086
NCI-V88-0322
Last Modified:
7/1/1989
5.
Phase III Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin II (Dihematoporphyrin Ethers) in Patients with Completely Obstructing Esophageal Carcinoma (Summary Last Modified 07/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
ACC-D73-P20
NCI-V89-0079
Last Modified:
5/1/1990
6.
Phase III Randomized Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin (Dihematoporphyrin Ethers) vs Thermal Ablation Therapy Using Nd:YAG Laser in Patients with Obstructing or Partially Obstructing non-Small Cell Bronchogenic Carcinoma (Summary Last Modified 05/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
ACC-D73-P17
NCI-V89-0076
Last Modified:
5/1/1990
7.
Phase III Randomized Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin (Dihematoporphyrin Ethers) plus Radiotherapy vs Radiotherapy Alone in Patients with Obstructing or Partially Obstructing non-Small Cell Bronchogenic Carcinoma (Summary Last Modified 05/90)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
ACC-D73-P18
NCI-V89-0077
Last Modified:
8/1/1989
8.
Phase III Randomized Study of the Safety and Efficacy of Photodynamic Therapy Using Photofrin (Dihematoporphyrin Ethers) vs Thermal Ablation Therapy Using an Nd:YAG Laser in Patients with Partially Obstructing Esophageal Carcinoma (Summary Last Modified 08/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
ACC-D73-P19
NCI-V89-0078
Last Modified:
6/1/1990
9.
Phase III Randomized, Comparative Study of Prophylactic Photodynamic Therapy Utilizing Photofrin II vs No Treatment Following Transurethral Resection in Patients with Superficial Transitional Cell Carcinoma of the Urinary Bladder
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
ACC-D73-P15
NCI-V90-0031
Last Modified:
11/1/1991
10.
Phase III Randomized, Comparative Study of Prophylactic Photodynamic Therapy Using DHE vs No Treatment Following Transurethral Resection in Patients with Superficial Transitional Cell Carcinoma of the Urinary Bladder (Summary Last Modified 11/91)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
TCSC-D73-P32
NCI-V91-0140
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute